I-Mab Skyrocketed

I-Mab (IMAB:NASDAQ) jumped higher at $39.44, representing a gain of 27.2%. On Fri 28 Aug 20, IMAB:NASDAQ hit a New 2-Week Intraday High of $33.51. The stock got featured on our News Catalysts scanner on Mon 31 Aug 20 at 07:37 AM in the 'INVESTOR UPDATE' category. From Fri 14 Aug 20, the stock recorded 40.00% Up Days and 27.27% Green Days

The share price of the company has been moving sideways in recent weeks.

About I-Mab (IMAB:NASDAQ)

I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company's product pipeline includes TJ202, TJ301, TJ107, TJC4, TJD5, and TJM2.